EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elimination of tau tangles and soluble aggregates with the small molecule ACI‐16664 prevents neurodegeneration in vivo

Nicolas Preitner, Véronique Dehlinger, Patrick Rodriguez, Kerstin Fabbri, Yvan Varisco, Matteo Pigni, Alessandra Lovison, Lucas Münzenmaier, Kasia Piorkowska, Aline Fuchs, Nadine Ait-Bouziad, Nicolas Fournier und 8 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Nicolas Preitner und 19 weiteren Autor:innen. Beteiligte Einrichtung: AC Immune SA, Lausanne, Switzerland. Hauptthemen laut MEDLINE: tau Proteins, Neurofibrillary Tangles, Tauopathies, Nerve Degeneration. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AC Immune SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Pathological tau aggregates are key therapeutic targets in Alzheimer's disease (AD), but current approaches face limitations including poor intracellular penetration, lack of selectivity for aggregated over physiological tau, or reliance on invasive administration. METHODS ACI‐16664, an orally available brain penetrant tau aggregation inhibitor, was identified through medicinal chemistry optimization of the Morphomer library and characterized using biochemical assays, neuronal cultures, and the Tg4510 tauopathy mouse model. RESULTS ACI‐16664 selectively bound aggregated tau with high apparent affinity, destabilized its β‐sheet structures, blocked intracellular seeding by both soluble and insoluble tau, and prevented tau‐induced neurotoxicity. In Tg4510 mice, ACI‐16664 reduced both soluble tau aggregates and tangles, and prevented neuronal loss, synaptic degeneration, and cortical atrophy. DISCUSSION These findings demonstrate the therapeutic value of targeting tau aggregation across its diverse pathological forms and cellular compartments, supporting the potential of this approach to benefit patients with AD and other tauopathies across disease stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsNeurofibrillary TanglesTauopathiesNerve DegenerationAnimalsHumansMiceMice, TransgenicDisease Models, AnimalNeuronsBrainAlzheimer DiseaseProtein Aggregation, Pathological

Stichwörter der Autor:innen

Alzheimer's diseasecortical atrophyneurodegenerationneurofibrillary tanglessmall moleculesoluble high‐molecular‐weight tausoluble tau aggregatessynapsestau aggregation inhibitortau oligomerstau pathologytau seedingtauopathy

Substanzen

tau Proteins

Autor:innen und Institutionen

  • AC Immune SA, Lausanne, Switzerland.

Förderung

  • AC Immune SA

Zitieren

APA

Preitner, N., Dehlinger, V., Rodriguez, P., Fabbri, K., Varisco, Y., Pigni, M., Lovison, A., Münzenmaier, L., Piorkowska, K., Fuchs, A., Ait-Bouziad, N., Fournier, N., Jepaul, S., Molette, J., Gabellieri, E., Darmency, V., Poli, S., Pfeifer, A., Kosco-Vilbois, M., & Capotosti, F. (2026). Elimination of tau tangles and soluble aggregates with the small molecule ACI‐16664 prevents neurodegeneration in vivo. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71572

Vancouver

Preitner N, Dehlinger V, Rodriguez P, Fabbri K, Varisco Y, Pigni M, et al. Elimination of tau tangles and soluble aggregates with the small molecule ACI‐16664 prevents neurodegeneration in vivo. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71572

BibTeX
@article{Preitner2026,
  author = {Preitner, Nicolas and Dehlinger, Véronique and Rodriguez, Patrick and Fabbri, Kerstin and Varisco, Yvan and Pigni, Matteo and Lovison, Alessandra and Münzenmaier, Lucas and Piorkowska, Kasia and Fuchs, Aline and Ait-Bouziad, Nadine and Fournier, Nicolas and Jepaul, Sandra and Molette, Jérôme and Gabellieri, Emanuele and Darmency, Vincent and Poli, Sonia and Pfeifer, Andrea and Kosco-Vilbois, Marie and Capotosti, Francesca},
  title = {Elimination of tau tangles and soluble aggregates with the small molecule ACI‐16664 prevents neurodegeneration in vivo},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71572}
}
Kostenlos starten →